Neuronetics to Participate at the 23rd Annual ICR Westwicke Conference

Neuronetics, Inc

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Chief Financial Officer, will be presenting at the 23rd Annual ICR Westwicke Conference, and participating in a panel discussion on Thursday, January 14, 2021.

23rd Annual ICR/Westwicke Conference (Presentation & Panel Discussion)
Thursday, January 14, 2021
Presentation Time: 12:15pm

Panel Name: Non-Drug Therapeutics: Devices Changing the Treatment Paradigm
Panel Time: 1:45 – 2:30pm

A live audio webcast of the ICR Westwicke Conference presentation will be available online at the investor relations page of the Company’s website at A replay of the webcast will be archived on the website for approximately 90 days.

Headquartered in Malvern, Pennsylvania, Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.

READ:  Verrica Announces Proposed Public Offering of Common Stock

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.